{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:09:00Z","timestamp":1793948940686,"version":"4.8.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Research and Development Projects in Key Fields in Guangdong Province","award":["2020B1111580001"],"award-info":[{"award-number":["2020B1111580001"]}]},{"DOI":"10.13039\/501100008366","name":"Guangdong Pharmaceutical University","doi-asserted-by":"publisher","award":["2024ZZ05"],"award-info":[{"award-number":["2024ZZ05"]}],"id":[{"id":"10.13039\/501100008366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009075","name":"Guangdong Academy of Sciences","doi-asserted-by":"publisher","award":["2024GDASZH-2024010102"],"award-info":[{"award-number":["2024GDASZH-2024010102"]}],"id":[{"id":"10.13039\/501100009075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009075","name":"Guangdong Academy of Sciences","doi-asserted-by":"publisher","award":["2024GDASZH-2024010101"],"award-info":[{"award-number":["2024GDASZH-2024010101"]}],"id":[{"id":"10.13039\/501100009075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009075","name":"Guangdong Academy of Sciences","doi-asserted-by":"publisher","award":["2022GDASZH-2022010110"],"award-info":[{"award-number":["2022GDASZH-2022010110"]}],"id":[{"id":"10.13039\/501100009075","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GDAS' Project of Science and Technology Development"},{"name":"Young Talent Project of GDAS","award":["2021TQ060920"],"award-info":[{"award-number":["2021TQ060920"]}]},{"name":"Young Talent Project of GDAS","award":["2023GDASQNRC-0201"],"award-info":[{"award-number":["2023GDASQNRC-0201"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108675","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T02:39:14Z","timestamp":1749177554000},"page":"108675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Discovery of novel PDE4 degraders with in vivo anti-inflammatory efficacy"],"prefix":"10.1016","volume":"163","author":[{"given":"Yuanhui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanghui","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianbao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108675_bb0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccc.2010.12.005","article-title":"Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury","volume":"27","author":"Cross","year":"2011","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.bioorg.2025.108675_bb0010","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1055\/s-2006-948296","article-title":"Treatment of acute lung injury: historical perspective and potential future therapies","volume":"27","author":"Levitt","year":"2006","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.bioorg.2025.108675_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112660","article-title":"Recent developments of small molecules with anti-inflammatory activities for the treatment of acute lung injury","volume":"207","author":"Chen","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108675_bb0020","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.2147\/DDDT.S280922","article-title":"4-Octyl Itaconate alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting oxidative stress and inflammation","volume":"14","author":"Li","year":"2020","journal-title":"Drug Design Dev. Therapy"},{"key":"10.1016\/j.bioorg.2025.108675_bb0025","first-page":"9","article-title":"Extracellular vesicles in the pathogenesis and treatment of acute lung injury","author":"Hu","year":"2022","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.bioorg.2025.108675_bb0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.108675_bb0035","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2025.108675_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115144","article-title":"Discovery of 4-oxo-N-phenyl-1,4-dihydroquinoline-3-carboxamide derivatives as novel anti-inflammatory agents for the treatment of acute lung injury and sepsis","volume":"249","author":"Yang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108675_bb0045","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/j.bmcl.2015.05.030","article-title":"Design, synthesis and biological evaluation of paralleled Aza resveratrol\u2013chalcone compounds as potential anti-inflammatory agents for the treatment of acute lung injury","volume":"25","author":"Chen","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108675_bb0050","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ejmech.2018.03.046","article-title":"Inhibitors of phosphodiesterase as cancer therapeutics","volume":"150","author":"Peng","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108675_bb0055","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","article-title":"Biochemistry and physiology of cyclic nucleotide Phosphodiesterases: essential components in cyclic nucleotide signaling","volume":"76","author":"Conti","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bioorg.2025.108675_bb0060","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.108675_bb0065","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41573-019-0033-4","article-title":"Therapeutic targeting of 3\u2032,5\u2032-cyclic nucleotide phosphodiesterases: inhibition and beyond","volume":"18","author":"Baillie","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.108675_bb0070","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00030.2010","article-title":"Mammalian cyclic nucleotide Phosphodiesterases: molecular mechanisms and physiological functions","volume":"91","author":"Francis","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bioorg.2025.108675_bb0075","doi-asserted-by":"crossref","first-page":"10594","DOI":"10.1021\/acs.jmedchem.9b02170","article-title":"Advances in the development of Phosphodiesterase-4 inhibitors","volume":"63","author":"Peng","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108675_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810616","article-title":"The complexity and multiplicity of the specific cAMP phosphodiesterase family: PDE4, open new adapted therapeutic approaches","volume":"23","author":"Lugnier","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108675_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116930","article-title":"Development of selective heterocyclic PDE4 inhibitors for treatment of psoriasis","volume":"280","author":"Li","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108675_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115195","article-title":"Advances in the development of phosphodiesterase-4 inhibitors","volume":"250","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108675_bb0095","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.3390\/molecules27154964","article-title":"An overview of PDE4 inhibitors in clinical trials: 2010 to early 2022","volume":"27","author":"Crocetti","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108675_bb0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/0929867323666151117121334","article-title":"Phosphodiesterase 4 (PDE4) inhibitors in the treatment of COPD: promising drug candidates and future directions","volume":"23","author":"Parikh","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108675_bb0105","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s40265-015-0463-1","article-title":"Roflumilast: A review in COPD","volume":"75","author":"Garnock-Jones","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2025.108675_bb0110","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.2022.14663","article-title":"Roflumilast for chronic plaque psoriasis","volume":"328","author":"Cordoro","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.bioorg.2025.108675_bb0115","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/all.16009","article-title":"Treatment of atopic dermatitis: recently approved drugs and advanced clinical development programs","volume":"79","author":"M\u00fcller","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.bioorg.2025.108675_bb0120","first-page":"S98","article-title":"Apremilast in psoriatic arthritis","volume":"33","author":"Schett","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bioorg.2025.108675_bb0125","doi-asserted-by":"crossref","first-page":"8448","DOI":"10.3390\/molecules27238448","article-title":"Emerging potential of the phosphodiesterase (PDE) inhibitor Ibudilast for neurodegenerative diseases: An update on preclinical and clinical evidence","volume":"27","author":"Angelopoulou","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108675_bb0130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejmech.2019.04.020","article-title":"InCl3 mediated heteroarylation of indoles and their derivatization via CH activation strategy: discovery of 2-(1H-indol-3-yl)-quinoxaline derivatives as a new class of PDE4B selective inhibitors for arthritis and\/or multiple sclerosis","volume":"174","author":"Sunke","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108675_bb0135","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1016\/j.bmcl.2018.04.068","article-title":"Tetrahydroquinoline and tetrahydroisoquinoline derivatives as potential selective PDE4B inhibitors","volume":"28","author":"Li","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108675_bb0140","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bmcl.2013.12.076","article-title":"Identification of the 5,5-dioxo-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives as highly selective PDE4B inhibitors","volume":"24","author":"Goto","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108675_bb0145","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1039\/c3ob27424a","article-title":"Novel N-indolylmethyl substituted olanzapine derivatives: their design, synthesis and evaluation as PDE4B inhibitors","volume":"11","author":"Gorja","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.108675_bb0150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41392-019-0101-6","article-title":"PROTACs: great opportunities for academia and industry","volume":"4","author":"Sun","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.108675_bb0155","doi-asserted-by":"crossref","first-page":"10141","DOI":"10.7150\/thno.46985","article-title":"The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination","volume":"10","author":"Jin","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bioorg.2025.108675_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115127","article-title":"Developments of PROTACs technology in immune-related diseases","volume":"249","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108675_bb0165","doi-asserted-by":"crossref","first-page":"8428","DOI":"10.1021\/acs.jmedchem.3c00302","article-title":"Recent advances in pro-PROTAC development to address on-target off-tumor toxicity","volume":"66","author":"Chen","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108675_bb0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13045-020-00885-3","article-title":"Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy","volume":"13","author":"Li","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2025.108675_bb0175","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1039\/D1CS00762A","article-title":"Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation","volume":"51","author":"Chen","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2025.108675_bb0180","article-title":"Nano proteolysis targeting chimeras (PROTACs) with anti-hook effect for tumor therapy","volume":"62","author":"Zhang","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.108675_bb0185","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1002\/anie.201913904","article-title":"Development of a PDE\u03b4-targeting PROTACs that impair lipid metabolism","volume":"59","author":"Winzker","year":"2020","journal-title":"Angewandte Chemie-Int. Ed."},{"key":"10.1016\/j.bioorg.2025.108675_bb0190","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1021\/acs.jmedchem.0c00929","article-title":"Discovery of novel PDEd degraders for the treatment of KRAS mutant colorectal Cancer","volume":"63","author":"Cheng","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108675_bb0195","doi-asserted-by":"crossref","first-page":"20353","DOI":"10.1021\/acs.jmedchem.4c01804","article-title":"Design, synthesis, and biological evaluation of new selective PDE4 inhibitors for topical treatment of psoriasis","volume":"67","author":"He","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108675_bb0200","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/anie.201507978","article-title":"Small-molecule PROTACS: new approaches to protein degradation","volume":"55","author":"Toure","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.108675_bb0205","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1021\/acschembio.5b00216","article-title":"Selective small molecule induced degradation of the BET Bromodomain protein BRD4","volume":"10","author":"Zengerle","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108675_bb0210","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.1021\/acs.jmedchem.9b00871","article-title":"Potent and preferential degradation of CDK6 via proteolysis targeting chimera degraders","volume":"62","author":"Su","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108675_bb0215","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1021\/jm501092z","article-title":"Small-Molecule Inhibitors of the MDM2\u2013p53 Protein\u2013Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment","volume":"58","author":"Zhao","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108675_bb0220","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2025.108675_bb0225","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nsmb.2874","article-title":"Structure of the human Cereblon\u2013DDB1\u2013lenalidomide complex reveals basis for responsiveness to thalidomide analogs","volume":"21","author":"Chamberlain","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bioorg.2025.108675_bb0230","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbi.2015.07.007","article-title":"Pituitary dendritic cells communicate immune pathogenic signals","volume":"50","author":"Glennon","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bioorg.2025.108675_bb0235","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","article-title":"Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes","volume":"400","author":"Bos","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2025.108675_bb0240","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5858\/arpa.2015-0519-RA","article-title":"Acute lung injury: A clinical and molecular review","volume":"140","author":"Butt","year":"2016","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.bioorg.2025.108675_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314959","article-title":"Pulmonary fibrosis as a result of acute lung inflammation: molecular mechanisms, relevant in vivo models, prognostic and therapeutic approaches","volume":"23","author":"Savin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108675_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpsurg.2020.100777","article-title":"Acute lung injury","volume":"57","author":"Mowery","year":"2020","journal-title":"Curr. Probl. Surg."},{"key":"10.1016\/j.bioorg.2025.108675_bb0255","article-title":"The role of macrophages polarization in sepsis-induced acute lung injury","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2025.108675_bb0260","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12950-023-00359-6","article-title":"IgG immune complex-induced acute lung injury is ameliorated by cAMP via down-regulation of C\/EBP- and AP-1-mediated transcriptions","volume":"20","author":"Yan","year":"2023","journal-title":"J. Inflamm."},{"key":"10.1016\/j.bioorg.2025.108675_bb0265","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/ITT.S40199","article-title":"Clinical potential of apremilast in the treatment of psoriatic arthritis","volume":"3","author":"Cauli","year":"2014","journal-title":"ImmunoTargets Therapy"},{"key":"10.1016\/j.bioorg.2025.108675_bb0270","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1021\/acs.jmedchem.4c02969","article-title":"Design, synthesis, and evaluation of selective PDE4 inhibitors for the therapy of pulmonary injury","volume":"68","author":"Li","year":"2025","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:51:08Z","timestamp":1776919868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825005553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":54,"alternative-id":["S0045206825005553"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108675","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel PDE4 degraders with in vivo anti-inflammatory efficacy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108675"}}